We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
-12.34%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
–
AUM
$469M
AUM Growth
+$6.3M
Cap. Flow
+$69M
Cap. Flow %
14.71%
Top 10 Hldgs %
56.27%
Holding
170
New
29
Increased
62
Reduced
27
Closed
12

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$13.7M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$8.31M
3
IJJ icon
iShares S&P Mid-Cap 400 Value ETF
IJJ
+$7.88M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.9M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$6.84M

Top Sells

Rank Stock Value
1
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$8.31M
2
VMC icon
Vulcan Materials
VMC
+$4.06M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.86M
4
IBB icon
iShares Biotechnology ETF
IBB
+$1.51M
5
ITA icon
iShares US Aerospace & Defense ETF
ITA
+$1.07M

Sector Composition

Rank Sector Weight
1 Technology 40.87%
2 Industrials 5.56%
3 Financials 4.87%
4 Consumer Discretionary 3.12%
5 Healthcare 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STON
151
DELISTED
StoneMor Inc.
STON
$104K 0.02%
49,509
– –
DYSL
152
DELISTED
Dynasil Corporation of America
DYSL
$101K 0.02%
113,465
– –
F icon
153
Ford
F
$57.3B
$87K 0.02%
11,350
-19,985
-64% -$178K
SSI
154
DELISTED
Stage Stores Inc
SSI
$70K 0.01%
94,400
– –
ESNC
155
DELISTED
EnSync Inc
ESNC
$58K 0.01%
320,376
-28,430
-8% -$6.14K
CYTO
156
DELISTED
Altamira Therapeutics Ltd
CYTO
$9K ﹤0.01%
+3
New +$15.3K
SGYP
157
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1K ﹤0.01%
11,200
-7,000
-38% -$4.59K
DUK icon
158
Duke Energy
DUK
$102B
– –
-5,870
Closed -$470K
GD icon
159
General Dynamics
GD
$105B
– –
-1,080
Closed -$221K
HNRG icon
160
Hallador Energy
HNRG
$718M
– –
-21,000
Closed -$131K
LOW icon
161
Lowe's Companies
LOW
$116B
– –
-1,800
Closed -$207K
MDLZ icon
162
Mondelez International
MDLZ
$77.7B
– –
-5,810
Closed -$251K
VMC icon
163
Vulcan Materials
VMC
$36.3B
– –
-36,494
Closed -$4.06M
ZWS icon
164
Zurn Elkay Water Solutions
ZWS
$8.07B
– –
-559,895
Closed -$8.31M
XTIA icon
165
XTI Aerospace
XTIA
$56.2M
– –
0
– -$30K
FG.WS
166
DELISTED
FGL Holdings Warrants exercisable for one Ordinary Share at a price of $11.50 per share
FG.WS
– –
-66,667
Closed -$131K
BPL
167
DELISTED
Buckeye Partners, L.P.
BPL
– –
-5,887
Closed -$210K
APU
168
DELISTED
AmeriGas Partners, L.P.
APU
– –
-9,500
Closed -$375K
ETP
169
DELISTED
Energy Transfer Partners, L.P.
ETP
– –
-10,545
Closed -$235K
CELG
170
DELISTED
Celgene Corp
CELG
– –
-3,500
Closed -$313K
3 4 5 6
7

Similar funds

CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
NG
Norden Group Provo, Utah $1.04B AUM 23.49% 1-Year Est. Return
RC
RDST Capital Seattle, Washington $1.04B AUM 0.4% 1-Year Est. Return
OPFM
Optimus Prime Fund Management Grand Cayman, Cayman Islands $1.04B AUM 9.64% 1-Year Est. Return
NFG
Nadler Financial Group Deerfield, Illinois $1.04B AUM 19.04% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
MGWM
Marks Group Wealth Management Minnetonka, Minnesota $1.04B AUM 8.96% 1-Year Est. Return

Crescent Grove Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Crescent Grove Advisors held 170 positions worth $469M, up 1.4% from $463M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Crescent Grove Advisors deployed $69M of net new capital in Q4 2018, opening 29 new positions and adding to 62 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 107,474 shares worth $7.45M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 43% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $2.86M trimmed.

  • Crescent Grove Advisors's largest Q4 2018 buy was iShares Core S&P Small-Cap ETF: 107,474 shares worth $7.45M.
  • Crescent Grove Advisors added most to iShares Core MSCI EAFE ETF in Q4 2018, an estimated $13.7M increase.
  • Crescent Grove Advisors's biggest Q4 2018 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $2.86M.
  • Crescent Grove Advisors fully exited Zurn Elkay Water Solutions in Q4 2018, selling an estimated $8.31M.
  • Crescent Grove Advisors's ten largest holdings make up 56% of its $469M portfolio in Q4 2018.
  • Crescent Grove Advisors opened 29 new positions and closed 12 in Q4 2018.
  • Crescent Grove Advisors's portfolio value rose 1.4% quarter-over-quarter to $469M.

Based on Crescent Grove Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.